Abstract
EE241 Fondaparinux: A Cost-Saving Alternative to Low-Molecular-Weight Heparins for Venous Thromboembolic Event Prevention/Treatment and Acute Coronary Syndrome Treatment
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have